Governance

FIND operates as a global health product development and delivery partnership.

Our work is guided by our Board of Directors. Our Board is the ultimate authority for all policies, organizational strategy and budget.

Our staff and Board are advised by a Scientific Advisory Committee (SAC), comprising senior scientists and experts in global health and diagnostics development. Our SAC provides advice on science and technology, assists in developing strategy, supports the scientific management process of projects, and offers expertise on issues ranging from diagnostics development to licensing.

An internal diversity, inclusion & safeguarding staff working group enables effective implementation of related policies, and is responsible for organizational measures that promote diversity and inclusion through specific recommendations to our leadership and Board.

Our digital health work is conducted in accordance with the Principles for Digital Development – established guidelines designed to support the integration of established best practices into technology-enabled programmes.

We are funded by donors, including bilateral and multilateral organizations, as well as private foundations.

Diagnostics and intellectual property

The pharmaceutical and vaccines industries both make regular use of patents to protect their innovative products. However, patents are less consequential for diagnostics. This document explains how intellectual property rights are protected in the diagnostics industry.